Clinic
Expecare, LLP
Expecare, LLP was paid $42K by Medicaid between Feb 2021 and Jun 2022, across 15 billing codes. Its largest line is 99202, Office or other outpatient visit for the evaluation and management of a new patient, straightforward — 22% of everything it billed.
33Billing provider infoEXPECARE, LLP
ARLINGTON, TX 76001
ARLINGTON, TX 76001
33aNPI1700151123assigned 03/19/2012
33bProvider typeUrgent Care Clinic/Center
28Total paid$42K
24GClaims2,273
24DCodes billed15
24AFirst – last monthFeb 2021 – Jun 2022
Compared with peers
Next to other Urgent Care Clinic/Center providers in Texas
Rank by total paid#94 of 151
Median peer was paid$125K
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 2,230 | $42K | |
| 2022 | 43 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 22% | 533 | 424 | $9K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 17% | 208 | 159 | $7K |
| 87631 | 14% | 65 | 62 | $6K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 9.3% | 125 | 105 | $4K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 9.0% | 109 | 106 | $4K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 7.6% | 437 | 355 | $3K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.5% | 128 | 99 | $2K |
| 87581 | 4.4% | 123 | 103 | $2K | |
| 87486 | 4.4% | 124 | 104 | $2K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 3.3% | 19 | 15 | $1K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2.5% | 12 | 12 | $1K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 94 | 77 | $416.78 |
3 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialOAD, MEHAR (CEO)